CiriacoM, VentriceP, RussoG, et al.Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother, 2013; 4:94–98.
2.
SarrisJ. Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders. Australas Psychiatry, 2017; 25:369–372.
3.
PapakostasGI, MischoulonD, ShyuI, et al.S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: A double-blind, randomized clinical trial. Am J Psychiatry, 2010; 167:942–948.
4.
CarneyMWP, TooneBK, ReynoldsEH. S-adenosylmethionine and affective disorder. Am J Med, 1987; 83:104–106.
5.
De BerardisD, OrsoliniL, SerroniN, et al.A comprehensive review on the efficacy of S-adenosyl-L-methionine in major depressive disorder. CNS Neurol Disord Drug Targets, 2016; 15:35–44.
6.
YamamotoT, YatsugiS-I, OhnoM, et al.Inhibition of mouse-killing behavior by S-adenosyl-L-methionine in midbrain raphe-lesioned and olfactory-bulbectomized rats. Pharmacol Biochem Behav, 1989; 34:395–398.
